My Dad tested positive for EGFR June 2013 and had been doing well on Tarceva, until progression early this year. He started Afantinib, with no CAT scan to test efficacy until later this month. The oncologist mention getting a second opinion. He is currently at a University hospital. What is the difference in mutation tested when provided by a company like Life Technologies?
Thank you, Greta